# CONMED agrees to acquire In2Bones Global for up to $255M

CONMED Corporation announced a definitive agreement to acquire In2Bones Global for $145 million at closing plus up to $110 million in earnout payments. In2Bones develops medical devices for extremities surgery.

- Type: Acquisition
- Announced: 2022-05-04
- Where: United States
- Value: $145.0M
- Status: announced
- Products: implants, fracture systems, biologics, extremities surgery devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CONMED Corporation](https://endata.com/companies/36116.md) (acquirer)
- [In2Bones Global](https://endata.com/companies/62693.md) (target)

## Sources

- [conmed.gcs-web.com](https://conmed.gcs-web.com/news-releases/news-release-details/conmed-announces-definitive-agreement-acquire-in2bones-global), 2022-05-04: "CONMED Corporation today announced a definitive agreement to acquire privately-held In2Bones Global, Inc., on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period."
- [massdevice.com](https://www.massdevice.com/conmed-beats-the-street-in-q1-announces-145m-deal-to-acquire-in2bones/), 2022-05-05: "This acquisition is a natural strategic extension of our orthopedic portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.